Sandoz and Teva invalidate blockbuster apixaban patent and SPC - JUVE Patent
Teva bullish ahead of 2-step biosimilar attack on AbbVie's blockbuster Humira
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/JO75YOO42VEHBMB23A37IROB7A.jpg "Teva announces Philadelphia-area layoffs of more than 200")
Teva announces Philadelphia-area layoffs of more than 200
Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning - WSJ
Teva Weighs Sale of $2 Billion Active Ingredients Unit - BNN Bloomberg
Teva Pharmaceuticals appoints Richard Francis CEO | HealthCare Middle East & Africa Magazine
Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg
Teva plans to sell Irvine drug plant – Orange County Register
Declining sales of blockbuster drug drag Teva revenue lower - MarketWatch
BioSpace on LinkedIn: Sanofi, Teva Ink Potential $1.5B Deal Aimed at Blockbuster IBD Drug |…
After Multiple Failures, Teva Returns Laquinimod Rights to Active Biotech | BioSpace
A determined FDA takes down Teva's blockbuster | Evaluate
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva Pharmaceuticals considers laying-off 10,000 workers - The Jerusalem Post
Israel's Teva gives upbeat outlook as restructuring proceeds | The Seattle Times
Teva hopes Sanofi collaboration will lead to blockbuster IBD drug | Reuters
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
/cloudfront-us-east-2.images.arcpublishing.com/reuters/G5JWOXLOQZIDLHFUUAR3HXPXEQ.jpg "Teva hopes Sanofi collaboration will lead to blockbuster IBD drug | Reuters")
Teva hopes Sanofi collaboration will lead to blockbuster IBD drug | Reuters
 "Zydus faces stiff competition for blockbuster drug in US from Teva Pharma")
Zydus faces stiff competition for blockbuster drug in US from Teva Pharma
Teva Launches First Generic to Blockbuster Cancer Med
Teva Pharmaceutical: Slow Road To A Higher Share Price (NYSE:TEVA) | Seeking Alpha
Teva's Blockbuster Drug Takes Another Generic Blow | Ctech
Generic-drug maker Teva steals market share from Big Pharma - Aug. 5, 2009
